Patients' understanding of oncology clinical endpoints: A literature review.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32273145.
- Also identified by DOI 10.1016/j.pec.2020.03.018 and PMC identifier 7423743.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Oncology clinical trials use a variety of clinical endpoints. Patients' understanding of the differences between clinical endpoints is important because misperceptions of treatment efficacy may affect treatment decisions. The objective of this literature review is to find and synthesize available empirical publications assessing patients' understanding of common oncology clinical endpoints. We conducted a literature search of 5 databases and 3 conferences, limiting the search to articles and abstracts published in English through September 2018. We reviewed the titles and abstracts for inclusion, then reviewed full texts to determine if they reported empirical research studies focused on (1) clinical endpoints, (2) oncology, and (3) patient understanding. The original search identified 497publications, of which 13 met the inclusion criteria. Available literature yields little information on this topic.The few publications that do exist suggest that healthcare professionals and cancer patients generally do not discuss clinical endpoint concepts and that patients can be confused about the purpose of a treatment based on misperceptions about endpoints. Research is needed on how to discuss oncology clinical endpoints with patients. Patient-friendly definitions of clinical endpoints may help healthcare providers communicate important information about treatments to patients.
Medical subject headings
- Clinical Trials as Topic
- Endpoint Determination
- Medical Oncology
- Neoplasms
- Patients